Global Rapid Acting Insulins Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rapid Acting Insulins Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Lispro
1.2.3 Aspart (NovoLog)
1.2.4 Glulisine (Apidra)
1.3 Market by Application
1.3.1 Global Rapid Acting Insulins Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rapid Acting Insulins Market Perspective (2017-2028)
2.2 Rapid Acting Insulins Growth Trends by Region
2.2.1 Rapid Acting Insulins Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Rapid Acting Insulins Historic Market Size by Region (2017-2022)
2.2.3 Rapid Acting Insulins Forecasted Market Size by Region (2023-2028)
2.3 Rapid Acting Insulins Market Dynamics
2.3.1 Rapid Acting Insulins Industry Trends
2.3.2 Rapid Acting Insulins Market Drivers
2.3.3 Rapid Acting Insulins Market Challenges
2.3.4 Rapid Acting Insulins Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rapid Acting Insulins Players by Revenue
3.1.1 Global Top Rapid Acting Insulins Players by Revenue (2017-2022)
3.1.2 Global Rapid Acting Insulins Revenue Market Share by Players (2017-2022)
3.2 Global Rapid Acting Insulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rapid Acting Insulins Revenue
3.4 Global Rapid Acting Insulins Market Concentration Ratio
3.4.1 Global Rapid Acting Insulins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rapid Acting Insulins Revenue in 2021
3.5 Rapid Acting Insulins Key Players Head office and Area Served
3.6 Key Players Rapid Acting Insulins Product Solution and Service
3.7 Date of Enter into Rapid Acting Insulins Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rapid Acting Insulins Breakdown Data by Type
4.1 Global Rapid Acting Insulins Historic Market Size by Type (2017-2022)
4.2 Global Rapid Acting Insulins Forecasted Market Size by Type (2023-2028)
5 Rapid Acting Insulins Breakdown Data by Application
5.1 Global Rapid Acting Insulins Historic Market Size by Application (2017-2022)
5.2 Global Rapid Acting Insulins Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Rapid Acting Insulins Market Size (2017-2028)
6.2 North America Rapid Acting Insulins Market Size by Country (2017-2022)
6.3 North America Rapid Acting Insulins Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Rapid Acting Insulins Market Size (2017-2028)
7.2 Europe Rapid Acting Insulins Market Size by Country (2017-2022)
7.3 Europe Rapid Acting Insulins Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rapid Acting Insulins Market Size (2017-2028)
8.2 Asia-Pacific Rapid Acting Insulins Market Size by Country (2017-2022)
8.3 Asia-Pacific Rapid Acting Insulins Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Rapid Acting Insulins Market Size (2017-2028)
9.2 Latin America Rapid Acting Insulins Market Size by Country (2017-2022)
9.3 Latin America Rapid Acting Insulins Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rapid Acting Insulins Market Size (2017-2028)
10.2 Middle East & Africa Rapid Acting Insulins Market Size by Country (2017-2022)
10.3 Middle East & Africa Rapid Acting Insulins Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Rapid Acting Insulins Introduction
11.1.4 Eli Lilly Revenue in Rapid Acting Insulins Business (2017-2022)
11.1.5 Eli Lilly Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Detail
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Rapid Acting Insulins Introduction
11.2.4 Novo Nordisk Revenue in Rapid Acting Insulins Business (2017-2022)
11.2.5 Novo Nordisk Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Rapid Acting Insulins Introduction
11.3.4 Sanofi Revenue in Rapid Acting Insulins Business (2017-2022)
11.3.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Rapid Acting Insulins Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Lispro
Table 3. Key Players of Aspart (NovoLog)
Table 4. Key Players of Glulisine (Apidra)
Table 5. Global Rapid Acting Insulins Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Rapid Acting Insulins Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Rapid Acting Insulins Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Rapid Acting Insulins Market Share by Region (2017-2022)
Table 9. Global Rapid Acting Insulins Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Rapid Acting Insulins Market Share by Region (2023-2028)
Table 11. Rapid Acting Insulins Market Trends
Table 12. Rapid Acting Insulins Market Drivers
Table 13. Rapid Acting Insulins Market Challenges
Table 14. Rapid Acting Insulins Market Restraints
Table 15. Global Rapid Acting Insulins Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Rapid Acting Insulins Market Share by Players (2017-2022)
Table 17. Global Top Rapid Acting Insulins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Acting Insulins as of 2021)
Table 18. Ranking of Global Top Rapid Acting Insulins Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Rapid Acting Insulins Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Rapid Acting Insulins Product Solution and Service
Table 22. Date of Enter into Rapid Acting Insulins Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rapid Acting Insulins Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Rapid Acting Insulins Revenue Market Share by Type (2017-2022)
Table 26. Global Rapid Acting Insulins Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Rapid Acting Insulins Revenue Market Share by Type (2023-2028)
Table 28. Global Rapid Acting Insulins Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Rapid Acting Insulins Revenue Market Share by Application (2017-2022)
Table 30. Global Rapid Acting Insulins Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Rapid Acting Insulins Revenue Market Share by Application (2023-2028)
Table 32. North America Rapid Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Rapid Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Rapid Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Rapid Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Rapid Acting Insulins Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Rapid Acting Insulins Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Rapid Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Rapid Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Rapid Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Rapid Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 42. Eli Lilly Company Detail
Table 43. Eli Lilly Business Overview
Table 44. Eli Lilly Rapid Acting Insulins Product
Table 45. Eli Lilly Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million)
Table 46. Eli Lilly Recent Development
Table 47. Novo Nordisk Company Detail
Table 48. Novo Nordisk Business Overview
Table 49. Novo Nordisk Rapid Acting Insulins Product
Table 50. Novo Nordisk Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million)
Table 51. Novo Nordisk Recent Development
Table 52. Sanofi Company Detail
Table 53. Sanofi Business Overview
Table 54. Sanofi Rapid Acting Insulins Product
Table 55. Sanofi Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Research Programs/Design for This Report
Table 58. Key Data Information from Secondary Sources
Table 59. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Rapid Acting Insulins Market Share by Type: 2021 VS 2028
Figure 2. Lispro Features
Figure 3. Aspart (NovoLog) Features
Figure 4. Glulisine (Apidra) Features
Figure 5. Global Rapid Acting Insulins Market Share by Application in 2021 & 2028
Figure 6. Type 1 Diabetes Case Studies
Figure 7. Type 2 Diabetes Case Studies
Figure 8. Rapid Acting Insulins Report Years Considered
Figure 9. Global Rapid Acting Insulins Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Rapid Acting Insulins Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Rapid Acting Insulins Market Share by Region: 2021 VS 2028
Figure 12. Global Rapid Acting Insulins Market Share by Players in 2021
Figure 13. Global Top Rapid Acting Insulins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Acting Insulins as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Rapid Acting Insulins Revenue in 2021
Figure 15. North America Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Rapid Acting Insulins Market Share by Country (2017-2028)
Figure 17. United States Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Rapid Acting Insulins Market Share by Country (2017-2028)
Figure 21. Germany Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Rapid Acting Insulins Market Share by Region (2017-2028)
Figure 29. China Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Rapid Acting Insulins Market Share by Country (2017-2028)
Figure 37. Mexico Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Rapid Acting Insulins Market Share by Country (2017-2028)
Figure 41. Turkey Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Rapid Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Eli Lilly Revenue Growth Rate in Rapid Acting Insulins Business (2017-2022)
Figure 44. Novo Nordisk Revenue Growth Rate in Rapid Acting Insulins Business (2017-2022)
Figure 45. Sanofi Revenue Growth Rate in Rapid Acting Insulins Business (2017-2022)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed